Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:

The Road to a Vaccine

eason 1 of The Road to a Vaccine is an eight-episode educational video series that examines the latest efforts to respond to the COVID-19 pandemic and breaks down the complex process of developing a coronavirus vaccine.

Host Lisa Ling talks to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world who are working collaboratively to bring an end to the deadly pandemic.

In Episode 5, two nurses—one on the front lines in the ICU, and one leading the charge to advocate for her profession—talk about what caring for patients, and each other, really means right now. An activist talks about recovering from the virus and a scientist shares the challenges of creating a vaccine for clinical. Plus, Arianna Huffington and Husseini K. Manji, MD, FRCPC, discuss the other COVID-19 crisis: how it's impacting mental health.

Season 1
Episode 5
How Nurses Are Battling the COVID-19 Pandemic
Meet Our Host
Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News' Nightline.
Macaya Douoguih, Head of Clinical Development & Medical Affairs, Janssen Vaccines
Season 1, Episode 5: J&J Expert Guest
Macaya Douoguih, M.D., M.P.H.
Macaya Douoguih, M.D., M.P.H.
Dr. Douoguih is Head of Clinical Development and Medical Affairs, Vaccines at the Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Douoguih heads a team of physicians and scientists that lead the clinical development of all viral and bacterial vaccine programs, including Ebola, RSV, HIV, E. coli and COVID-19 vaccines.
Season 1, Episode 5: Expert Guest
Elman is a 5-board accredited life coach, presenter and activist. She's spoken at events for the Teenage Cancer Trust, Women’s Health Live and Stylist Live and has written for publications such as the Huffington Post, Metro, Stylist Magazine, the Daily Mail, Cosmo and Grazia. She is also the author of the book, “Am I Ugly?”.
Season 1, Episode 5: Expert Guest
Huffington is the founder and CEO of Thrive Global, a leading behavior change tech company with the mission of changing the way we work and live. She's also the founder of The Huffington Post, the author of 15 books including, most recently, "Thrive" and "The Sleep Revolution," and has been named to Time Magazine's list of the world’s 100 most influential people.
Season 1, Episode 5: Expert Guest
Nicole Lincoln MS, RN, FNP-BC, CCNS
Nicole Lincoln MS, RN, FNP-BC, CCNS
Lincoln is a Critical Care Clinical Nurse Specialist and proud long-time bedside RN from Boston, Massachusetts. Her passion for nursing is deeply rooted in health equity, curiosity, innovation, caring and compassion. With 25 years of experience in critical care, education, innovation, quality improvement, nurse mentoring and leadership, she is looking forward to coaching the next generation of bright nurse leaders, innovators, scientists and entrepreneurs.
Season 1, Episode 5: Expert Guest
Love is a nurse entrepreneur, inventor, author, TedX speaker, the first nurse featured on and part of the inaugural nursing panel featured at SXSW 2018. Love was also the first Director of Nurse Innovation & Entrepreneurship in the United States at Northeastern School of Nursing—a founding initiative designed to empower nurses as innovators and entrepreneurs.
Season 1, Episode 5: J&J Expert Guest
Johnson & Johnson’s Dr. Manji oversees all neuroscience programs investigating treatments for mood disorders, schizophrenia, and neurodegenerative diseases, such as Alzheimer’s disease. Previously, Dr. Manji was Chief of the Laboratory of Molecular Pathophysiology & Experimental Therapeutics at the National Institutes of Health (NIH).
The video series, hosted by journalist and author Lisa Ling, delves into efforts to create a potential COVID-19 vaccine.
Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.